Professional health association support and prior registration for obstetric use were found to be critical factors in securing national regulatory approval of misoprostol and mifepristone for medical abortion, a new study has found.
Julia White recently joined the Coalition as its new Market Development Technical Officer, joining from PSI, where she was working as a Technical Advisor on a multi-million dollar global women’s health project focusing on increasing access to long-term contraception, safe abortion services and post-abortion care in 15 countries.
Categories: Market Development Approaches Working Group
Peru’s Health Minister Patricia Garcia announced on Tuesday that emergency contraception (EC) will be offered free of charge at the country’s state hospitals within 30 days.
The Reproductive Health Supplies Coalition seeks proposals to implement one or more market shaping recommendations from the report Increasing Access to Essential Maternal Health Supplies. Proposals should focus on work in...
Categories: Maternal Health Supplies Caucus